Pharmaceutical Price Regulation Scheme

The National Health Service (NHS) spends about £9 billion a year on branded prescription medicines in the UK. The Pharmaceutical Price Regulation Scheme (PPRS) is the mechanism which the Department of Health (on behalf of the UK health departments) uses to ensure that the NHS has access to good quality branded medicines at reasonable prices. The scheme seeks to achieve a balance between reasonable prices for the NHS and a fair return for the industry to enable it to research, develop and market new and improved medicines.

11th report to Parliament on PPRS

The Department has today published the 11th report to Parliament on the Pharmaceutical Price Regulation Scheme (PPRS). The PPRS regulates prices of branded prescription medicines and the profits that manufacturers … Read more → – 11th report to Parliament on PPRS

Published: 23 February, 2012

PPRS Dispute Resolution Panel’s decision published

The decision of the Pharmaceutical Price Regulation Scheme Dispute Resolution Panel on the matter brought before it by the Association of the British Pharmaceutical Industry is published. It concerned the … Read more → – PPRS Dispute Resolution Panel’s decision published

Published: 20 January, 2012

Pharmaceutical Price Regulation Scheme dispute resolution decisions published

Two decisions by the Pharmaceutical Price Regulation Scheme Dispute Resolution Panel have been published. The latest decisions to be published are those regarding the Department of Health and King Pharmaceuticals … Read more → – Pharmaceutical Price Regulation Scheme dispute resolution decisions published

Published: 27 July, 2011